A Study to Assess the Role of Technology for the Detection of Hearing Loss

Overview

About this study

The purpose of this study is to evaluate available tablet-based technology that can be easily used to screen and monitor patients for the detection of hearing loss in a quiet, clinic setting.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Individuals aged 18-80 years old.
  • Scheduled to receive a hearing test as part of Executive Health Program.
  • Able to give informed consent.
  • English-speaking.

Exclusion Criteria: 

  • Patients < 18 years or > 80 years old.
  • Non-English speaking (instructions on tablet in English-only).
  • Specialized populations (adult developmentally delay, cognitive decline, etc.).
  • Vulnerable populations (e.g., prisoners, severe mentally illness etc.).
  • Additional handicap that would limit the patient from being able to follow study instructions.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Gayla Poling, Ph.D.

Open for enrollment

Contact information:

Paula Orr CCRP

(507)284-1231

Orr.Paula@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available